Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Looking back at the growth of synthetic chemistry, the introduction of fluorine into aromatic compounds changed the way scientists designed pharmaceuticals. The fluoro and trifluoromethyl groups in particular made a difference, offering new possibilities in optimizing biological performance. Decades ago, pyrimidine-2,4-dione derivatives entered the stage during efforts to improve anti-viral drugs, sparking off a series of innovations. Today, 1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione stands out as a result of eager research in medicinal chemistry, shaped by a drive to increase both stability and selectivity. Labs worldwide began reporting novel synthetic routes in the early 2000s, with Asian and European firms scaling up production by addressing environmental and safety issues tied to fluorinated intermediates. Each improvement brought researchers closer to a product suitable not only for laboratory study but also for pharmaceutical-grade supply, ensuring the compound could meet stringent BP, EP, and USP monograph criteria.
1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione serves as a key piece in drug discovery, especially in the development of anti-viral and oncological agents. Featuring both a pyrimidine core and a fluorinated aromatic ring, this compound shows structural complexity that supports medicinal exploration. Pharmaceutical manufacturers demand high purity for clinical use. Suppliers meet these requirements by building robust purification steps, cutting impurities down to sub-percent levels. As the industry moves toward next-level therapies, this molecule continues gaining recognition for the stability that trifluoromethyl and fluorine substituents offer, protecting against rapid degradation and undesirable metabolic pathways.
The crystalline solid generally appears white to off-white, which stems from the rigidity introduced by its aromatic and heterocyclic rings. The addition of trifluoromethyl and fluoro groups gives the structure high lipophilicity, making it less soluble in water but more at home in non-polar, pharmaceutical solvents. Melting points usually fall in the 140-160°C range, a point of pride for labs focusing on thermal analysis. Molecular weight hovers around 328-330 g/mol, taking into account all the heavy fluorine atoms. The chemical structure also gives it good resistance to hydrolysis and oxidation under laboratory or formulation handling, streamlining both storage and transportation.
Quality standards for BP, EP, and USP pharma grades call for tight control of impurities, clear identification methods, and strict moisture content limits. Each shipment features full traceability—from batch number to country of origin—alongside a certificate of analysis confirming that UV, IR, and HPLC analysis match published spectra. Labels highlight storage conditions, hazard information, and compliance with current Good Manufacturing Practice (cGMP) guidelines. Customers can scan QR codes for instant access to material safety data sheets and recent laboratory validation results, promoting transparency in every step. The physical container itself, often HDPE or amber glass, provides chemical resistance and blocks UV light, protecting material integrity between labs and manufacturing lines.
Organic synthesis routes for this molecule often draw on strategic alkylation of a pyrimidine-2,4-dione core using the 2-fluoro-6-trifluoromethyl-benzyl halide as a key reagent. Many chemists start from easily available methyl uracil, using a strong base and a carefully measured dropwise addition of the benzylic halide at controlled temperatures. Reaction monitoring continues via thin-layer chromatography or HPLC, tracking the transformation from starting material to target product. Isolation involves stepwise extraction, drying, then recrystallization from anhydrous solvents under inert atmosphere. The final compound goes through advanced purification—such as silica gel column chromatography or preparative HPLC—to achieve pharma-grade purity. Operators check residual solvents and confirm structural identity with NMR, MS, and elemental analysis.
The molecule’s pyrimidine ring opens possibilities for further N-alkylation, arylation, or even halogen exchange, which can tailor biological activity for new indications. The trifluoromethyl and fluoro substituents influence the aromatic ring’s electron density, shielding it from some common nucleophilic attacks but making it more reactive toward electrophilic aromatic substitution under extreme conditions. Medicinal chemists sometimes introduce additional groups at the 5-position of the pyrimidine to diversify therapeutic prospects, but every change goes through rigorous in vitro and metabolic stability screening. Efforts continue to make the benzylic link more robust, as benzylic positions can remain metabolically vulnerable in some mammalian systems.
This compound goes by several names in lab and commercial catalogues: 1-(2-Fluoro-6-Trifluoromethylbenzyl)-6-Methyluracil, 2,4-Dioxo-6-methyl-1-[(2-fluoro-6-(trifluoromethyl)phenyl)methyl]-1,2,3,4-tetrahydropyrimidine, and CAS Number 129453-61-8 in some databases. Pharmaceutical buyers compare CAS and INN nomenclature to avoid confusion, as generic and synonym listings can trip up procurement if catalogues use alternate spellings or representations. Regulatory filings will use the full systematic IUPAC name, matching documentation standards in patent and clinical trial submissions.
Safety assessments from raw material sourcing to final packaging now rely on precision tools rather than guesswork. Handling instructions advise using gloves, masks, and ventilated enclosures, since dust or powder form can irritate mucous membranes. Companies install exhaust and filtration systems in production suites to limit airborne concentrations. Fire hazards remain low due to the dense, non-volatile structure, but development teams maintain Class D extinguishing agents for lab-scale incidents. Compliance checks regularly examine adherence to REACH and TSCA guidelines, aiming to eliminate contamination of water or soil. Audits confirm standardized processes for hazard communication, employee training, and emergency procedures.
Drug designers focus on this molecule’s potential in anti-viral and anti-cancer drug frameworks. Its stability in biological fluids and resistance to rapid metabolic breakdown make it a backbone for compounds seeking long half-lives or oral bioavailability. Pharmaceutical firms use this derivative to create pro-drug candidates or as a starting scaffold in combinatorial chemistry screens. Researchers in academic labs study the molecule alongside new inhibitors for polymerase enzymes, tuning the structure to fit the shape and charge of target proteins. Regulatory pathways for clinical approval often cite published work on analogs to demonstrate expected safety and efficacy, getting a head start over lesser-known building blocks.
Academic and industry labs keep expanding the chemistry around 1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione, working to attach the molecule to delivery systems and nanoparticles for targeted therapies. Structure-activity relationship (SAR) studies compare performance against dozens of analogues in virus-infected cell models, focusing on how tiny changes in the benzyl or pyrimidine half can swing potency one way or another. Patent filings in the last decade highlight creative molecular modifications, as research groups fight to protect new discoveries and win exclusivity. Research teams regularly attend conferences to trade learnings on the best crystallization solvents or latest data-mining techniques, making collaboration the name of the game when unique compounds like this push the boundaries of what’s treatable.
No new compound gets a free pass into medicine cabinets, so safety evaluation steps up alongside chemical innovation. Labs run detailed toxicity batteries on 1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione, tracking acute oral and dermal toxicity across animal models. Eye and skin irritation tests gauge safe handling limits for chemists and operators, reflected in updated safety data sheets. Chronic dosing studies look for mutagenic, teratogenic, and reproductive risks. Some analogues show altered liver enzyme interactions tied to the fluorinated benzyl group, prompting further in vivo screening cycles before any candidate gets a green light for phase one trials. Investigators use mass spectrometry and metabolic pathway tracing to watch for biologically active breakdown products as a double-check.
With pressure building for tougher, more precise therapies, attention on fluorinated pyrimidine derivatives will likely keep ramping up. Machine learning and AI-aided design scan molecular libraries, constantly selecting for candidates with optimal pharmacokinetic traits. Scale-up production pivots to more sustainable green chemistry approaches, using less solvent and energy. Larger clinical studies set new endpoints, hoping to prove the value of molecules like this for unmet medical needs. As global drug development faces emerging threats, a strong pipeline of rigorously tested, well-characterized compounds like 1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione keeps innovation alive—even as industry standards shift toward more transparent, responsible research.
Working in pharmaceutical science, you come across many tongue-twisting names for chemicals. Still, 1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione stands out. Its chemistry speaks to stability and unique biological activity. The structure brings a tough mix of fluorine atoms and a pyrimidine-dione core. Those fluorine atoms often show up in drug design for a reason: they can make a molecule harder to break down in the body, which can mean more reliable medication schedules and fewer pills to remember.
This molecule didn't spring up from nowhere. The design leans heavily on the backbone of uracil derivatives. Chemists used similar blueprints to create drugs for cancer and HIV in the past. With the right tweaks, those molecules get the power to block DNA synthesis. By blocking how quickly cells copy DNA, drugs made from this core can help slow down certain viral infections or tumor growth.
Big names in drug discovery keep pushing rare molecules like this toward treatments for life-threatening diseases, since resistance to older drugs keeps popping up. Finding a molecule that gives viruses or cancer cells trouble in their DNA copying process—without clobbering healthy tissue—matters.
Every time I've walked into a GMP-compliant lab, the standards for purity and quality come up in conversation. Pharmaceutical grade versions of this compound—BP, EP, USP—get put through tough checking to weed out impurities. Putting these versions into clinical trials or commercial use means fewer problems for patients, less risk for toxicity, and more predictable effects.
A focus on this kind of pharmaceutical grade material also reflects a commitment to patient safety. With global agencies watching for fraud and contamination, providing a defined, certified product keeps the trust of doctors and patients.
Several published studies reference closely related compounds for their abilities as DNA polymerase inhibitors. Working with oncologists and infectious disease specialists, research groups have moved molecules like this to pre-clinical or even early-stage clinical trials. Researchers keep aiming for better oral availability and fewer side effects, thanks to the fluorinated structure, which often means longer half-life and less dosing hassle.
Experience has shown that the pyrimidine-dione family takes well to small adjustments, so this molecule forms a toolkit for medicinal chemists to try new combinations. In discovery meetings, we talk about "lead optimization"—tweaking a molecule like this so it binds viral enzymes tightly but leaves human cells mostly alone.
From my years following drug development meetings, it’s clear that molecules like this will keep drawing interest for anti-cancer and antiviral uses. Speeding up the process from lab to bedside takes public research support, open data sharing, and a regulatory process that cuts through red tape but never skips safety checks.
Gaps remain—resistance can wipe out a medicine’s usefulness over time. Encouraging more collaboration between chemists, regulators, and clinicians will allow for safer, faster rollouts. Investing in toxicology screens and early biomarkers for response will sort the winners from the rest before large patient populations get exposed.
People need treatments they can trust. 1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione represents not just clever lab work, but the promise of tackling the toughest diseases—when commitment, science, and practical know-how all meet.
Every lab worker knows the sting of opening an old reagent bottle that’s turned brown, grown crystals, or just doesn’t smell the same anymore. Many chemicals, even common ones, break down if they spend too much time outside their ideal temperature range or pick up moisture from the air. At my first research gig, we had a rule: no unmarked bottles and no guesswork. If a reagent went off, the results became junk, and both time and money vanished with it.
Most compounds need cool, dry, and dark spots to stay stable. A fridge between 2–8°C keeps reactions from going haywire, especially for things like enzyme mixes or organics that degrade fast. Sunlight also triggers unwanted chemical changes, which explains why amber glass bottles line the shelves. Some shelf staples like sodium chloride last ages, but fancier chemicals, such as certain pharmaceuticals or specialty reagents, end up with much shorter clocks.
Humidity creeps in even through screw-top lids, and not every manufacturer uses protective inner seals. In hot, sticky parts of the world, desiccators become your best allies, trading moisture for longevity. Anyone who’s returned to a summer lab can spot the telltale clumps of ruined powder or rusty caps. Temperature swings speed up spoilage; sensitive materials like peptides lose potency and sometimes turn useless long before the label claims if left on an open bench.
Actual shelf life numbers vary a lot. Standard antibiotics, for example, might keep two to three years sealed, but break down in weeks once dissolved. I once watched a group throw out thousands of dollars’ worth of research materials because simple dehydration turned a stable reagent into an unreliable mess. That mistake’s easy to make if you stash bottles in the nearest cabinet instead of dedicated cold storage.
Keeping a clean stockroom means more than just buying fresh supplies. Every bottle should carry a clear date of receipt and opening. Most commercial labels fade or become illegible with time, especially around acids or volatile solvents. It pays off to use indelible marker and back up records with digital logs. Without them, people start cutting corners, taking a sniff or a guess instead of proper verification. That doesn’t just ruin experiments; it risks safety.
Placing silica gel packs in with moisture-sensitive solids stretches their shelf life. Rotating stock – using the oldest bottles first – prevents forgotten chemicals from turning into waste. Investing in temperature alarms and humidity sensors costs a little up front but saves resources and headaches later. Simple habits, like never touching the rim of a bottle or always sealing lids right after use, actually add up over time.
Strict storage might feel tedious, especially in a fast-paced research setting, but it pays dividends. I’ve seen tight controls make the difference between a year of decent results and months of troubleshooting failed reactions. Ask the old hands about batch failures from spoiled supplies, and you’ll hear almost the same advice: respect your chemicals, track them well, and don’t skimp on protection. That’s the backbone of reliable research and safe, cost-effective lab work.
Pharmaceutical manufacturing rarely leaves room for uncertainty. Whether a product claims compliance with the British Pharmacopoeia (BP), European Pharmacopoeia (EP), or United States Pharmacopeia (USP), buyers should expect precise standards matched with concrete evidence. Pharmacopeia standards serve as contract promises — not wishlist features. If a label says a substance is BP, EP, or USP grade, it means the product should meet strict criteria covering identity, purity, and safety, as outlined by these long-established pharmacopeias.
In everyday conversation with pharmacists and regulatory consultants, I find people often assume that “compliant” means “premium quality.” That isn’t always the case. Compliance refers to meeting specific, published rules — some of which are updated frequently. For example, USP has changed specifications for excipients, adding new tests for impurities and residues. British and European standards sometimes diverge, even in aspects like allowable elemental impurities or test methodology. Relying on assumptions can leave room for mistakes, delays, and financial loss.
Certifications should never rest on marketing claims alone. Anyone involved in procurement for pharmaceutical production can describe the importance of a full Certificate of Analysis (COA). The COA provides details documenting relevant batch-specific test results, detection limits, and analytical methods. A legitimate COA from a manufacturer or qualified distributor allows the buyer to verify compliance without guesswork. Inconsistent or missing data stands as a red flag. If an audit reveals gaps or discrepancies, the entire shipment can be wasted and regulatory actions set in motion. I’ve seen teams scramble to answer regulators with “paperwork” after the fact—almost always at much greater cost than getting the certification right from the start.
It’s easy to overlook certifications beyond the COA. Regulators increasingly ask for GMP (Good Manufacturing Practice) certificates and audit reports, not just chemical specs. Traceability of manufacturing and storage conditions play large roles. In Europe, failure to keep clear GMP documentation has led to stops on imports. In the United States, the FDA now demands full trace-back for some ingredients, especially after contamination incidents in past years. If a company doesn’t furnish these documents or hesitates when asked, that forms real cause for concern.
Product recalls linked to subpar imports have left lasting scars across the industry. Shortcuts to source cheaper products from unfamiliar markets draw attention when quality slips or standards don’t truly match the label. Patients rely on tested, regulated medicine. Distributors who seek to bypass compliance, even unintentionally, risk regulatory fines, legal action, and, most importantly, harm to patient health. I’ve watched established brands lose years of trust and spend fortunes regaining lost ground after compliance lapses.
Quality-assurance specialists recommend thorough supplier vetting, not just for one order but as ongoing practice. Check supplier audit records. Visit the facility if possible. Cross-reference the product batch numbers and specification sheets against the latest BP, EP, or USP monographs. Don’t hesitate to commission independent testing from certified labs—results can provide a critical double check on both identity and purity. Digital track-and-trace systems also help consolidate records for regulatory review in a way old stacks of documents cannot.
Demanding answers backed by documented proof is not just regulatory box-ticking; it makes real sense for both patient safety and a business’s reputation. Consistent, documented compliance with BP, EP, and USP shouldn’t be viewed as an achievement — it’s a baseline expectation for anyone participating in modern pharmaceutical supply chains.
Walk into a grocery store or search online for pantry staples, cleaning products, or even electronics. Chances are, you’ll spot the same brand sitting in a tiny pouch, a bulky jug, a rigid box, and something in between. Businesses aren’t just giving more options for the sake of it. These packaging choices grow out of real habits and the changing priorities people have.
Some shoppers want a quick fix: a single serving, an energy drink to grab in the morning, or a snack to slip in a backpack. These smaller packs cut down on food waste and fit snugly into today’s on-the-go life. Bigger households—or careful bargain hunters—can save money and reduce trips by picking up value-sized bags of detergent or jumbo boxes of cereal. People with limited space often want a compact jar, not a family-sized drum.
Think about coffee. Pods, single-serve sachets, 250-gram bags, and even 1-kilo tins each play a different role. Pods are great for a fast morning routine but come with extra packaging waste. Bulk beans look greener, but only work if you have room and drink enough before the beans go stale. Brands constantly juggle sustainability, convenience, and cost to meet different expectations.
More folks read labels now. Some look for sugar count or allergens, others for trustworthy certifications. Smaller packaging helps companies give clear, targeted information—like individual wrappers on allergy-friendly snacks or single-use medicine packs that show dosage and safety codes upfront. Transparent packaging, like clear clamshells or windowed bags, lets shoppers see the product quality and freshness for themselves.
On the flip side, all these options can drown us in garbage. Flexible pouches, most food wrappers, and composite containers make recycling tough. Glass jars and plain cardboard win points with eco-conscious buyers but weigh more and cost more to ship. There’s a tradeoff between less waste at home and more efficient shipping and shelf life. Some stores let you refill your own containers or use biodegradable packs, which offer a bit of hope to those who worry about plastic waste piling up.
A packaging label doesn’t tell the whole story. Storage, safety, waste, and the simple act of lifting a bottle all shape the way people buy. In my own family, switching from large milk jugs to smaller cartons kept us from tossing spoiled milk. Single-portion yogurt means less fighting over flavors, fewer leftovers, and more recycling hassle. It’s a balancing act.
Companies can help make smarter packaging choices by providing life cycle information, offering refill models, or simplifying materials so more can be recycled curbside. Shoppers can nudge brands by choosing eco-friendly options and speaking up about packaging excess. Small changes—like buying bigger packs if you can use them up, or picking brands with take-back programs—add up.
Packaging tells the story of what matters to consumers: saving time, spending wisely, wasting less, and caring about what ends up in the trash. Making better choices, from both companies and buyers, will shape how future generations shop and live.
Accidents involving chemicals or dangerous goods change lives in a heartbeat. I’ve seen workers wipe their brow with hands stained by something they couldn’t even name, thinking the gloves weren’t necessary. Tiny moments like these remind me that safety gear isn’t just taking up space in a toolbox. Gloves, goggles, and well-fitted masks help turn a risky job into a routine one. Some folks may scoff at boots or reflective clothing, but falling short on protective measures brings real consequences—injuries, lawsuits, loss of trust. That’s not worth it.
Manufacturers print instructions and warnings on packaging for a reason. If something spills or reacts badly, chasing hints online won’t help. Check those labels every time. If you don’t recognize a symbol or term, ask a supervisor or consult the safety data sheet. I remember a supervisor who insisted we quiz each other about labels before each shift. It paid off—on a rough day, knowing what not to mix stopped a close call from turning ugly.
Proper storage means more than piling boxes neatly on a pallet. Heavier items go at the bottom, fragile stuff stays up top, and all containers stay dry and undamaged. A dented drum can leak or burst. If you wouldn’t feel comfortable keeping something next to your sandwich, it shouldn’t skate by inspection. Double-check seals and lids. One loose cap can cause more chaos than a flat tire, and others pay the price if someone cuts corners.
Before loading chemicals onto a truck, separation makes a difference. Flammable liquids shouldn’t snuggle next to oxidizers. Rules exist about safe distances and container limits for a reason. Every time I worked a loading dock, I counted and spaced out the goods, even if a driver urged me to speed up. Getting things wrong puts lives at risk, not just deliveries.
Anyone with access to hazardous tools or chemicals deserves training that’s more than a box to tick. Stories and hands-on demos last longer in memory. Watching a senior staff member walk us through an emergency drill taught me far more than a distant video ever could. Simulated spills and fire drills sharpen instincts and build muscle memory. Regulations like OSHA’s HazCom and DOT guidelines aren’t just paperwork; they demand practical action. Seasoned trainers share tales where rules protected lives and made an ordinary day in the warehouse stay that way.
Accidents happen—spill kits and fire extinguishers extinguish mistakes before they turn tragic. Every person working with hazardous products should know the escape routes, phone numbers, and cleanup plans. If something leaks or ignites, guessing wastes precious seconds. Drills and refresher courses should never gather dust; a practiced, confident response beats panic every time.
More than anything, honest communication and a strong safety culture drive results. Speak up if gear feels inadequate or labeling seems unclear. Investing in thorough training, regular checks, and open dialogue saves money and, more importantly, lives. Regulations and labels only work if people respect them. Knowing what’s at stake keeps everyone honest and safe.
| Identifiers | |
| 3D model (JSmol) | `3Dmol.js('{3Dmol.viewer("gldiv1", {backgroundColor:"white"}).addModel("CC1=CNC(=O)NC1=O", "smi").setStyle({stick:{}}).render();}')` |
Chengguan District, Lanzhou, Gansu, China
